Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Clinically Isolated Syndrome Suggestive of Multiple Sclerosis: Dynamic Patterns of Gray and White Matter Changes-A 2-year MR Imaging Study.
Natalizumab in the pediatric MS population: results of the Italian registry.
Hyaluronan oligosaccharides perturb lymphocyte slow rolling on brain vascular endothelial cells: Implications for inflammatory demyelinating disease.
Effect of autoimmune diseases on risk and survival in female cancers.
Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS Expert Group.
Risk Factors Associated with the Onset of Relapsing-Remitting and Primary Progressive Multiple Sclerosis: A Systematic Review.
Immunosuppressive treatments in multiple sclerosis.
Multiple sclerosis: Atacicept increases relapse rates in multiple sclerosis.
Stressful life-events in childhood and risk of multiple sclerosis: a Danish nationwide cohort study.
Neuroimaging and cognition using functional near infrared spectroscopy (fNIRS) in multiple sclerosis.
Erythromelalgia-like presentation of chronic acquired demyelinating polyneuropathy in a setting of past alcohol abuse.
Vitamin D: Health Panacea or false Prophet?
Clinical predictors of an optimal response to natalizumab in multiple sclerosis.
Platelets and neurovascular inflammation.
Use of a Time-of-Flight Camera With an Omek Beckon™ Framework to Analyze, Evaluate and Correct in Real Time the Verticality of Multiple Sclerosis Patients during Exercise.
Teriflunomide: A Review of Its Use in Relapsing Multiple Sclerosis.
Diagnosis and classification of neuromyelitis optica (Devic's Syndrome).
The role of B cells in the onset of the first demyelinating event of optic neuritis.
Neuromyelitis optica: atypical clinical and neuroradiological presentation.
Scan-stratified case-control sampling for modeling blood-brain barrier integrity in multiple sclerosis.
The common marmoset as a novel animal model system for biomedical and neuroscience research applications.
Structural Brain MR Imaging Changes Associated with Obsessive-Compulsive Disorder in Patients with Multiple Sclerosis.
Fingolimod-associated amenorrhea: a report of three cases.
Are specialty drug prices destroying insurers and hurting consumers?: a number of efforts are under way to reduce price pressure.
Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis.
Pages
« first
‹ previous
…
289
290
291
292
293
294
295
296
297
…
next ›
last »